Loading...
Market
Will Novo Nordisk complete acquisition of Catalent by mid-2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Press releases from Novo Nordisk or Catalent; official filings
Story
Senator Warren Urges FTC to Scrutinize Novo Nordisk's $16.5 Billion Catalent ($CTLT) Deal
Oct 10, 2024, 04:05 PM
US Senator Elizabeth Warren has called for regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk's parent foundation would acquire Catalent ($CTLT), a contract drug manufacturer. Warren urged the Federal Trade Commission (FTC) to investigate whether the deal would give Novo Nordisk ($NVO) an unfair advantage in the market for obesity and diabetes drugs. She expressed concerns about the potential control Novo Nordisk would gain over some of Catalent's plants.
View original story
Similar markets
Significantly increase • 25%
Slightly increase • 25%
No change • 25%
Decrease • 25%
Increase by more than 5% • 25%
Increase by 1-5% • 25%
No significant change • 25%
Decrease • 25%
Top 5 • 25%
Top 10 • 25%
Top 20 • 25%
Below Top 20 • 25%
Growth above 10% • 25%
Growth 5-10% • 25%
Growth below 5% • 25%
No growth • 25%
Yes • 50%
No • 50%
